Bringing doctors together

or

A free, private network for verified physicians

  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    JRDr. Jesse Richards
    Leading Voice

    Dr. Jesse Richards

    Internal Medicine · Obesity Medicine & Nutrition
    University of Oklahoma Health Sciences Center
    jesser

    Research

    Consensus-based clinical and research recommendations for use of glucagon-like peptide-1 receptor agonists in the context of eating disorders: a modified Delphi study

    2026

    Via World Psychiatry

    Research

    Streamlining Diagnosis of Bardet-Biedl Syndrome: New Diagnostic Algorithm With Updated Criteria

    2026

    Via American Journal of Medical Genetics Part A

    Research

    Obesity medications and acquired hypothalamic obesity in adults: A two-case experience

    2026

    Via Obesity Pillars

    Research

    Gastrointestinal-related side effects are key barriers to dietary fiber intake

    2025

    Via Nutrition and Health

    Research

    Defining Hyperphagia for Improved Diagnosis and Management of MC4R Pathway–Associated Disease: A Roundtable Summary

    2025

    Via Current Obesity Reports

    Research

    Improving the diagnosis of hyperphagia in melanocortin‐4 receptor pathway diseases

    2025

    Via Obesity

    Research

    Bariatric outcomes of high BMI patients with preoperative anti-obesity medications

    2025

    Via Surgical Endoscopy

    Research

    Obesity treatment as a bridge to solid organ transplantation: A comparison of bariatric surgery to medical therapy

    2025

    Via Obesity Pillars

    Research

    Knowledge, Attitudes, and Practices in the Management of Childhood and Adolescent Obesity: A Survey of Primary Care Providers in the State of Oklahoma, USA

    2025

    Via Journal of Community Health

    Research

    Case Report: Improvement in cognitive functioning following setmelanotide initiation in a patient with Bardet-Biedl syndrome

    2025

    Via Frontiers in Endocrinology

    Research

    Nutritional considerations with antiobesity medications

    2024

    Via Obesity

    Research

    Highway to the danger zone? A cautionary account that GLP-1 receptor agonists may be too effective for unmonitored weight loss

    2024

    Via Obesity Reviews

    Research

    Safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta-analysis

    2024

    Via Obesity Reviews

    Research

    Significantly higher rates of KIDINS220 polymorphisms in patients with obesity and end-stage renal disease

    2024

    Via Obesity Pillars

    Research

    Use of GLP-1 agonists in high risk patients prior to bariatric surgery: a cohort study

    2023

    Via Surgical Endoscopy